Type 1 Error in Website Experiments: False Wins, Risk, and Prevention

Before a website experiment can declare a winner, the team needs to know how many different paths can authorize rollout and what stopping rule applies. A dashboard that shows “95% significance” cannot answer that on its own: peeking, multiple metrics, selective segments, or invalid measurement can turn a nominal 5% false-positive rate into much larger false-win exposure.

A Type I error is the specific case in which a test rejects a null hypothesis that is actually true, as the NIST definition states. For a standard website A/B test, the null hypothesis commonly says that the treatment and control have the same underlying value for the decision metric. A false win occurs when random variation makes the treatment look different enough to reject that no-effect claim.

That does not mean experimentation is defective. It means a randomized A/B test is a decision procedure under uncertainty, not a machine that reveals ground truth after one run. Good design makes the uncertainty explicit and controls how often the procedure will make a particular kind of mistake.

Alpha controls a procedure, not the truth of one winner#

For one valid hypothesis test, the Type I error rate is written:

α = P(reject H₀ | H₀ is true)

Read the expression from right to left: assuming the null hypothesis really is true, alpha is the probability that the specified procedure rejects it. If a fixed-horizon website test is validly calibrated at α = 0.05, then across many repetitions in which the treatment has no effect, about 5% can cross the rejection threshold by chance.

Here is a clearly marked illustrative example, not company data. Imagine repeatedly running an A/A test: visitors are randomly assigned, but both variants are identical. If the assumptions and implementation are sound, a 0.05 test can still produce a statistically significant “difference” in roughly 5 of every 100 such repetitions. Microsoft describes this expected behavior in its work on simulated A/A tests.

The neighboring error points the other way. A Type II error occurs when the test fails to reject a false null hypothesis—a missed real effect. Its probability is beta, β, and power is 1 − β. With a fixed design, lowering alpha generally makes false wins less likely but real effects harder to detect. More independent sample can improve power while alpha stays fixed; it does not, by itself, change a correctly calibrated 0.05 procedure into a lower-alpha test.

A per-test false-positive rate is also different from the family-wise error rate, which asks whether at least one false rejection occurs across a defined family, and the false discovery rate, which concerns the expected share of false discoveries among discoveries. Those quantities answer different risk questions; none is the posterior probability that this particular winner is false.

One 5% test can become a 40% search for a win#

The single-test promise is easy to break operationally. A website dashboard may show several variants, success metrics, segments, and date ranges. If the team will ship when any one of those comparisons looks favorable, it has created several chances to find a winner.

For m independent tests, all with true null hypotheses and each tested at alpha, the chance of at least one false rejection is:

FWER = 1 − (1 − α)ᵐ

FWER is the family-wise error rate: the probability of one or more Type I errors in the family. Independence is important to this exact formula. Website metrics and segments are often correlated, so the arithmetic is an illustration of compounding opportunities, not a plug-in estimate for every dashboard.

Consider another illustrative example, not company data. A team gives 10 independent metrics equal authority to declare one variant a winner, tests each at α = 0.05, and in truth the variant changes none of them:

FWER = 1 − 0.95¹⁰ = 0.4013

The chance of at least one false win is about 40.1%, not 5%. A simple Bonferroni plan aimed at a 5% family-wise rate would test each of the 10 hypotheses at 0.05 ÷ 10 = 0.005. Under independence, the chance of at least one false rejection would then be 1 − 0.995¹⁰ = 0.0489, or about 4.9%. The Bonferroni inequality documented by NIST gives the at-most-5% family-wise bound without requiring independence.

Bonferroni is transparent, but it can be conservative. Other procedures control other quantities. The false discovery rate, for example, concerns the expected share of false discoveries among discoveries rather than the probability of even one false discovery. Microsoft documents false-discovery adjustment for a large alerting workflow, while Optimizely documents a tiered Benjamini–Hochberg implementation for its own experiment results. Those are real implementations, not permission to assume that every platform badge controls the same error across exported segments, custom queries, and repeated decisions.

False wins enter through the decision rule#

Multiplicity is defined by what can change the decision, not by how many charts happen to be visible. Ten diagnostics that cannot independently authorize rollout are not the same as ten success metrics where any favorable result can produce a ship call. Conversely, one chart can conceal many opportunities if the team repeatedly changes its segment, endpoint, or date range until the chart turns green.

The rule for stopping deserves special attention because experiment dashboards invite continuous observation. Johari and colleagues’ always-valid inference paper shows why conventional fixed-horizon p-values and intervals become unreliable when users choose sample size by watching the accumulating result. Their sequential methods are designed for data-dependent stopping under stated conditions. Ordinary p-values do not acquire that property because a team calls its behavior “monitoring.”

The same discipline applies to metric roles. A primary success metric, a harm guardrail, an instrumentation check, and a diagnostic measure answer different questions. Research presenting Spotify’s risk-aware multi-metric framework shows that adjustments depend on the logical decision rule and on whether a metric tests success, non-inferiority, deterioration, or quality. Counting every metric and dividing alpha mechanically is not a substitute for stating what each metric is allowed to do.

Not every false conclusion is a Type I error#

A useful audit separates three failures that dashboards often collapse into one “false positive” label.

First, a Type I error under a valid procedure is the chance event the procedure was designed to limit. Assignment, exposure, measurement, model assumptions, hypothesis family, and stopping rule are intact, but this repetition lands in the rejection region even though the null is true.

Second, an invalid experiment can create a false conclusion because the nominal procedure no longer describes the data. A variant may fail to render, identifiers may place the same person in both experiences, treatment may change logging, bots or outliers may distort a metric, or the observed allocation may depart from the configured ratio. Calling all of this “the 5% risk” is misleading: the displayed alpha does not repair broken randomization or measurement.

Microsoft’s pre-experiment patterns recommend measurable hypotheses, appropriate metric roles, power planning on affected randomization units, stable identifiers, and pre-period checks. Its A/A work uses known-null assignments to test whether metric p-values behave as expected, while its alerting system uses sample-ratio checks to surface assignment and setup problems.

Third, a bad business rollout can follow a true statistical result. With enough precision, an extremely small nonzero change may be statistically distinguishable from zero. If that change cannot repay implementation cost, does not persist on a decision-relevant outcome, or breaches a guardrail, shipping it can still be wrong. That is not a Type I error when the statistical null is genuinely false; it is a mismatch between the tested hypothesis and the business decision.

This distinction matters during a postmortem. Random error calls for better error budgeting or confirmation. Invalidity calls for repairing the experiment system and rerunning from clean data. A trivial-but-real effect calls for a minimum meaningful effect and a better decision rule. Treating all three as bad luck leaves the actual failure untouched.

Set false-win tolerance from the decision#

α = 0.05 is a common convention, not a universal website-experiment benchmark. The acceptable false-win exposure depends on what a positive result authorizes, how reversible the change is, how costly a mistaken rollout would be, how many hypotheses can trigger action, and what is lost by missing a real improvement.

A lower alpha reduces the planned probability of a Type I error, but it is not free. At a fixed sample size and effect, stricter evidence usually lowers power and raises Type II risk. Maintaining power at a lower alpha generally requires more independent sample. Penn State’s sample-size guidance treats alpha, desired power, a meaningful effect, and variability as joint design inputs rather than settings to choose one at a time.

The better operating question is therefore not “Do we always use 95% significance?” It is: What false decision are we controlling, across which set of opportunities, and what evidence is sufficient for the action this result will trigger? A reversible copy change and an experiment that changes lead qualification may justify different review and confirmation policies even if both use the same statistical engine.

Statistical significance remains only one gate. A rollout decision should also examine the estimated effect, its uncertainty interval, the minimum effect worth acting on, guardrails, data-quality checks, and the cost of being wrong. The ASA’s guidance is direct: conclusions and business decisions should not rest only on whether a p-value passes a threshold.

A practical false-win control sheet#

Prevention works best when the team writes one compact decision contract before traffic enters the experiment. The contract does not need a statistical derivation, but it must give the analyst and decision owner the same answer to these questions:

During the run, preserve assignment and the metric definition. Investigate data-quality alerts without changing the success rule to match what looks promising. If the method is fixed-horizon, observing a dashboard for operational safety is different from repeatedly making a statistical ship decision; only the predeclared decision time governs the primary inference. If continuous decisions are necessary, use and document a sequential method that supports them.

At readout, inspect validity before lift. Then report the primary estimate and interval, the analysis method, the full decision-relevant family, any multiplicity adjustment, guardrails, and deviations from plan. Secondary and segment findings can be valuable hypothesis generators, but discovery in the same data is weaker than confirmation. Preserve “no win” and inconclusive outcomes so the experimentation program does not quietly become a collection of selected successes.

Four questions that prevent common misreads#

Does more traffic eliminate Type I error? No. If a valid procedure retains α = 0.05, more independent sample mainly narrows uncertainty and increases power for a specified effect. The nominal Type I rate remains controlled at alpha. More sample can support a stricter alpha while retaining power, but only if the design changes accordingly.

Can a team know whether one specific significant result is a Type I error? Usually not from the same experiment alone, because the true treatment effect is not directly observed. The team can audit whether the procedure was valid, examine the effect and interval, compare the result with prior evidence, and seek independent confirmation when the decision warrants it. A borderline p-value is not a hidden label that identifies a false win.

Is a p-value of 0.049 meaningfully trustworthy while 0.051 is not? A prespecified threshold gives a consistent decision rule, but those neighboring values contain nearly the same graded evidence under the same model. Neither reports the probability that the winner is true, and neither describes business value. Report the estimate and uncertainty rather than turning the threshold into a credibility cliff.

Does failing to reach significance prove there is no effect? No. It means the specified procedure did not reject the null. The result may be compatible with no effect, a harmful effect, or a useful effect that the design could not resolve. The uncertainty interval and minimum meaningful effect show which possibilities remain open; power planning shows what the experiment was capable of detecting.

Start with one explicit decision, define the family of ways evidence can trigger it, and match the multiplicity and stopping method to that family. Then verify that assignment and measurement earned the right to interpret the result. If the team cannot state those boundaries, it does not yet have a defensible winner—only a favorable dashboard state.